Sensient Technologies Corporation Second Quarter 2024 Earnings Call July 26, 2024

Non-GAAP Financial Measures 2 Within this document, the Company reports certain non-GAAP financial measures, including: (1) adjusted operating income, adjusted net earnings, and adjusted diluted earnings per share, which exclude restructuring and other costs, including the Portfolio Optimization Plan costs and (2) percentage changes in revenue, operating income, and diluted earnings per share on an adjusted local currency basis, which eliminate the effects that result from translating its international operations into U.S. dollars and restructuring and other costs, including the Portfolio Optimization Plan costs, and (3) adjusted EBITDA (which excludes Portfolio Optimization Plan costs and non-cash share based compensation expense). The Company has included each of these non-GAAP measures in order to provide additional information regarding our underlying operating results and comparable year-over-year performance. Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. These non-GAAP measures should not be considered in isolation. Rather, they should be considered together with GAAP measures and the rest of the information included in this report. Management internally reviews each of these non-GAAP measures to evaluate performance on a comparative period-to-period basis and to gain additional insight into underlying operating and performance trends, and the Company believes the information can be beneficial to investors for the same purposes. These non-GAAP measures may not be comparable to similarly titled measures used by other companies.

Forward Looking Statements This document contains statements that may constitute “forward-looking statements” within the meaning of Federal securities laws including under “2024 Financial Outlook” and "Business Initiatives and Outlook" in this presentation. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties, and other factors concerning the Company’s operations and business environment. Important factors that could cause actual results to differ materially from those suggested by these forward-looking statements and that could adversely affect the Company’s future financial performance include the following: the Company’s ability to manage general business, economic, and capital market conditions, including actions taken by customers in response to such market conditions, and the impact of recessions and economic downturns; the impact of macroeconomic and geopolitical volatility, including inflation and shortages impacting the availability and cost of raw materials, energy, and other supplies, disruptions and delays in the Company’s supply chain, and the conflicts between Russia and Ukraine and Israel and Hamas and other parties in the Middle East; the availability and cost of labor, logistics, and transportation; the pace and nature of new product introductions by the Company and the Company’s customers; the Company’s ability to anticipate and respond to changing consumer preferences and changing technologies; the Company’s ability to successfully implement its growth strategies; the outcome of the Company’s various productivity- improvement and cost-reduction efforts, acquisition and divestiture activities, and Portfolio Optimization Plan; industry, regulatory, legal, and economic factors related to the Company’s domestic and international business; the effects of tariffs, trade barriers, and disputes; growth in markets for products in which the Company competes; industry and customer acceptance of price increases; actions by competitors; the Company’s ability to enhance its innovation efforts and drive cost efficiencies; currency exchange rate fluctuations; and other factors included in “Risk Factors” in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, and in other documents that the Company files with the SEC. The risks and uncertainties identified above are not the only risks the Company faces. Additional risks and uncertainties not presently known to the Company or that it currently believes to be immaterial also may adversely affect the Company. Should any known or unknown risks and uncertainties develop into actual events, these developments could have material adverse effects on our business, financial condition, and results of operations. This presentation contains time- sensitive information that reflects management’s best analysis only as of the date of this presentation. Except to the extent required by applicable laws, the Company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied herein will not be realized. 3

Q2 2024 Consolidated Results 5 (1) See appendix for our GAAP to Non-GAAP reconciliations.

Revenue Strong volume growth due to new wins Revenue increased 11% during the quarter Operating Income Impacted by elevated costs related to certain agricultural inputs in our natural ingredients product line Flavors & Extracts Group Performance Local Currency1 Results Commentary Group Outlook2 Upgraded Mid-to high single-digit local currency revenue1 growth Operating leverage to improve sequentially 6 (1) See appendix for our GAAP to Non-GAAP reconciliations. (2) Represents outlook as of our earnings release provided on July 26, 2024, and does not constitute an update or reissuance as of any later date

Revenue Increase in revenue driven by new wins All product lines contributed to growth in the quarter Operating Income Operating leverage returned due to improved volumes and sales mix Color Group Performance Local Currency1 Results Commentary Group Outlook2 Upgraded Mid-to high single-digit local currency revenue1 growth Operating leverage to continue to improve in back half of the year 6 (1) See appendix for our GAAP to Non-GAAP reconciliations. (2) Represents outlook as of our earnings release provided on July 26, 2024, and does not constitute an update or reissuance as of any later date

Revenue Growth driven by increase in new sales win rate Growth across most regions in the second quarter Operating Income Growth driven by higher volumes in the Group in second quarter Asia Pacific Group Performance Local Currency1 Results Commentary Group Outlook2 Upgraded High single-digit local currency revenue1 growth 6 (1) See appendix for our GAAP to Non-GAAP reconciliations. (2) Represents outlook as of our earnings release provided on July 26, 2024, and does not constitute an update or reissuance as of any later date

9 Local Currency Revenue2 o Growth rate of mid-to high single-digit Local Currency Adjusted EBITDA2 Growth rate of mid-to high single-digit Local Currency Adjusted EPS2 Growth rate of mid-single-digit Business Initiatives and Outlook1 Consolidated Outlook Portfolio Optimization Plan On track to deliver $8 to $10 million in annual savings, once fully implemented, by the end of 2025 Project is progressing as expected Inventory Management Reduction of $45 million in the inventory balance in the first half of 2024 Business Initiatives Represents outlook as of our earnings release provided on July 26, 2024, and does not constitute an update or reissuance as of any later date See appendix for our GAAP to Non-GAAP reconciliations.

Innovative Natural Colors Support Growth Sensient has a portfolio of solutions to replace TiO2 and Red 3 Generally, replacements are not one-size-fits-all and require support from Sensient’s application experts Coupling our broad portfolio of replacements with our technical expertise ensures Sensient can meet our customer needs Sensient's application expertise and focus on innovation is a pillar of our growth strategy 10

Q2 2024 Financial Review 12 (dollars in thousands) Q2 2023 Q2 2024 Revenue Local Currency Revenue Growth1 $ 374,313 $ 403,525 +8.5% Operating Income (GAAP) Operating Margin $ 51,591 13.8% $ 49,657 12.3% Adjusted Operating Income1 Adjusted Operating Margin1 $ 51,591 13.8% $ 51,409 12.7% Diluted EPS (GAAP) $ 0.81 $ 0.73 Adjusted Diluted EPS1 $ 0.81 $ 0.77 Adjusted EBITDA1 $ 68,530 $ 69,341 Consolidated Commentary: Local currency revenue1 increased 8.5% Q2 2024 results included $1.8 million of Portfolio Optimization Plan costs (approximately 4 cents per share) Operating income impacted by higher year-over-year performance-based compensation Operating margin impacted by higher costs in certain agricultural inputs and higher performance-based compensation (1) See appendix for our GAAP to Non-GAAP reconciliations.

2024 Cash Flow and Debt Metrics 13 YTD Cash Flow from Operations $ 58.9 million Capital Expenditures $ 22.9 million Total Debt (as of June 30) $ 661.7 million Net debt to credit adjusted EBITDA1 2.6x Commentary: Cash flow from operations improved $7.2 million compared to 2023, primarily due to a continued focus on improving our inventory position Capital expenditures were down $22.3 million compared to prior year (1) See appendix for our GAAP to Non-GAAP reconciliations.

2024 Financial Outlook1 14 Metric Updated Guidance Prior Guidance Local Currency Revenue2 Mid-to high single-digit growth Mid-single-digit growth Local Currency Adjusted EBITDA2 Mid-to high single-digit growth Mid-single-digit growth Diluted EPS (GAAP)3 $2.77 to $2.87 $2.80 to $2.90 Local Currency Adjusted Diluted EPS2 Mid-single-digit growth Low to mid-single-digit growth Capital Expenditures $65 to $70 million ~ $65 million Adjusted Effective Tax Rate ~ 25% Between 24% and 25% Interest Expense Increase over prior year Increase over prior year Represents outlook as of our earnings release provided on July 26, 2024, and does not constitute an update or reissuance as of any later date See appendix for our GAAP to Non-GAAP reconciliations. Diluted EPS (GAAP) now includes $0.18/share of Portfolio Optimization Plan costs. Prior guidance included $0.15/share of plan costs. Total plan costs are still expected to be approximately $40M.

Appendix1 (1) Amounts in thousands, except percentages and per share amounts

Non-GAAP Financial Measures 20 2024 2023 % Change Operating income (GAAP) $ 49,657 $ 51,591 (3.7%) Portfolio Optimization Plan costs – Cost of products sold Portfolio Optimization Plan costs – Selling and administrative expenses 207 1,545 - - Adjusted operating income $ 51,409 $ 51,591 (0.4%) Net earnings (GAAP) $ 30,932 $ 34,033 (9.1%) Portfolio Optimization Plan costs, before tax 1,752 - Tax impact of Portfolio Optimization Plan costs(1) (214) - Adjusted net earnings $ 32,470 $ 34,033 (4.6%) Diluted earnings per share (GAAP) $ 0.73 $ 0.81 (9.9%) Portfolio Optimization Plan costs, net of tax 0.04 - Adjusted diluted earnings per share $ 0.77 $ 0.81 (4.9%) Note: Earnings per share calculations may not foot due to rounding differences. (1) Tax impact adjustments were determined based on the nature of the underlying non-GAAP adjustments and their relevant jurisdictional tax rates. Three Months Ended June 30,

Revenue Total Foreign Exchange Rates Adjustments(1) Adjusted Local Currency Flavors & Extracts 11.1% 0.0% N/A 11.1% Color 4.5% (0.7%) N/A 5.2% Asia Pacific 7.1% (4.0%) N/A 11.1% Total Revenue 7.8% (0.7%) N/A 8.5% Operating Income Flavors & Extracts 7.2% (0.2%) 0.0% 7.4% Color 7.8% (1.0%) 0.0% 8.8% Asia Pacific 4.0% (5.2%) 0.0% 9.2% Corporate & Other 65.0% 0.0% 18.1% 46.9% Total Operating Income (3.7%) (1.4%) (3.4%) 1.1% Diluted Earnings Per Share (9.9%) (2.5%) (4.9%) (2.5%) Adjusted EBITDA 1.2% (1.1%) N/A 2.3% 20 Non-GAAP Financial Measures Three Months Ended June 30, 2024 (1) Adjustments consist of Portfolio Optimization Plan costs.

Non-GAAP Financial Measures 20 Three Months Ended June 30, 2024 Revenue Total Foreign Exchange Rates Local Currency Flavors, Extracts and Flavor Ingredients 0.8% 0.0% 0.8% Natural Ingredients 36.4% 0.0% 36.4% Flavors & Extracts Group 11.1% 0.0% 11.1% Food and Pharmaceutical 4.3% (0.4%) 4.7% Personal Care 5.1% (1.5%) 6.6% Color Group 4.5% (0.7%) 5.2% Asia Pacific 7.1% (4.0%) 11.1% Total revenue 7.8% (0.7%) 8.5%

Non-GAAP Financial Measures Results by Segment Operating Income Adjusted Adjusted 2024 Adjustments(1) 2024 2023 Adjustments(1) 2023 Flavors & Extracts $ 26,209 $ - $ 26,209 $ 24,456 $ - $ 24,456 Color 31,502 - 31,502 29,217 - 29,217 Asia Pacific 7,880 - 7,880 7,575 - 7,575 Corporate & Other (15,934) 1,752 (14,182) (9,657) - (9,657) Consolidated $ 49,657 $ 1,752 $ 51,409 $ 51,591 $ - $ 51,591 Three Months Ended June 30, (1) Adjustments consist of Portfolio Optimization Plan costs. 20

Non-GAAP Financial Measures 2024 2023 % Change Operating income (GAAP) $ 49,657 $ 51,591 (3.7%) Depreciation and amortization 15,016 14,440 Share-based compensation expense 2,916 2,499 Portfolio Optimization Plan costs, before tax 1,752 - Adjusted EBITDA $ 69,341 $ 68,530 1.2% Three Months Ended June 30, 20

Non-GAAP Financial Measures 20 Debt 2024 2023 Short-term borrowings $ 26,995 $ 15,436 Long-term debt 634,663 686,589 Credit Agreement adjustments(1) (18,034) (19,755) Net Debt $ 643,624 $ 682,270 Operating income (GAAP) $ 151,657 $ 191,147 Depreciation and amortization 58,955 54,877 Share-based compensation expense 9,078 12,213 Portfolio Optimization Plan costs, before tax 32,405 - Other non-operating gains(2) (872) (3,326) Credit Adjusted EBITDA $ 251,223 $ 254,911 Net Debt to Credit Adjusted EBITDA 2.6x 2.7x (1) Adjustments include cash and cash equivalents, as described in the Company's Third Amended and Restated Credit Agreement (Credit Agreement), and certain letters of credit and hedge contracts. (2) Adjustments consist of certain financing transaction costs, certain non-financing interest items, and gains and losses related to certain non-cash, non-operating, and/or non-recurring items as described in the Credit Agreement. June 30,